Breakthroughs in weight loss drugs have drawn new interest to biotech stocks. Non addictive pain medications that go beyond Tylenol and Advil are another huge area being explored by a number of biopharma’s. Vertex pharmaceuticals is one of them, we’ll review their progress in the Market Intel Segment, then discuss a remarkable opportunity being created by higher interest rates. MASTERING MONEY is on the air!!!